Beyond Air, Inc. (XAIR)

Beyond Air, Inc., a clinical-stage medical device and biopharmaceutical company, develops nitric oxide (NO) delivery systems to treat respiratory tract infections and other diseases. Its NO delivery systems are used for the treatment of pulmonary hypertension of the newborn, bronchiolitis, and nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. The company is based in Garden City, New York.

Current Quote*
Last: $6.900
Change: -0.160
Book: $8.218
Volume: 66,531

As Of: 05/29 13:03 ET
*Quotes delayed by 20min.

Graphs for XAIR


3 Month Graph


6 Month Graph


1 Year Graph